Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28676388 | 0.89 | MAOA (0.37) | MAOAMAOBELANECYP1A2CYP2A6 | |
| SCHEMBL28662627 | 0.83 | MAOA (0.33) | MAOAMAOBELANECYP1A2CYP2A6 | |
| SCHEMBL28219900 | 0.80 | TDP1 (0.37) | MAOAMAOBELANECYP1A2CYP2A6 | |
| SCHEMBL27933145 | 0.74 | LMNA (0.40) | CYP1A2 | |
| SCHEMBL22616873 | 0.73 | MAOA (0.38) | MAOAMAOBELANECYP1A2CYP2A6 | |
| SCHEMBL28947796 | 0.72 | CA1 (0.35) | MAOAMAOBELANECYP1A2CYP2A6 | |
| SCHEMBL28660740 | 0.71 | MAOA (0.37) | MAOAMAOBELANECYP1A2CYP2A6 | |
| SCHEMBL28666655 | 0.71 | MAOA (0.37) | MAOAMAOBELANECYP1A2CYP2A6 | |
| SCHEMBL27378068 | 0.71 | MAOA (0.37) | MAOAMAOBELANECYP1A2CYP2A6 | |
| SCHEMBL13967835 | 0.70 | CA1 (0.45) | MAOAMAOBELANECYP1A2CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113748140-A | Metal-ligand complexes | 陶氏环球技术有限责任公司 | 2021-12-03 | — | — | CN | disclosed |